News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Actelion Ltd. Drug, Iloprost May Prevent Lung Cancer, US Study Finds
May 19, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- A drug approved to treat a range of conditions may also work to prevent lung cancer in people who have given up smoking, U.S. researchers reported on Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
MORE ON THIS TOPIC
Psychedelics
Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’
September 14, 2026
·
3 min read
·
Heather McKenzie
Breast cancer
AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger market
September 14, 2026
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH VIVA BIOTECH
Cyclic peptides open new drug frontiers, if manufacturing can keep up
September 14, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Psychedelics
Psychedelic therapies ride wave of public favor into FDA hearing
September 14, 2026
·
3 min read
·
Michael Gibney